semaglutide age A new study from UC San Diego offers early clinical evidence that semaglutide, a widely used GLP-1 receptor agonist, may slow biological aging. In a randomized, placebo-controlled trial, researchers observed a 9% GLP-1 use growing fastest among

Mounjaro offers the strongest overall results for patients with metabolic issues or insulin resistance

Among the most discussed peptides is CJC-1295, a synthetic analogue of Growth Hormone Releasing Hormone (GHRH)

No guaranteed outcomes

Prescribing Trends in Glucagon-Like Peptide-1 Medications Among Pregnant and Postpartum Persons

For example, fatigue could stem from nutrient shortages or hormonal shifts, while mood issues might link to neurotransmitter irregularities

Custom Medication Plan Based on your needs, we prescribe Semaglutide or Tirzepatide, with precise dosing adjustments for optimal fat loss and minimal side effects